Glenn P. Sblendorio
Glenn P. Sblendorio

Glenn P. Sblendorio

Director

Glenn P. Sblendorio has served as a member of our Board since June 2006. Most recently, Mr. Sblendorio was Chief Executive Officer and a member of the Board of Directors of IVERIC bio, Inc., formerly Ophtotech Corporation, from July 2017 until it was acquired by Astellas Pharma in May of 2023. Prior to IVERIC, Mr. Sblendorio was President and Chief Financial Officer of The Medicines Company from March 2006 through March 2016 and was a member of the Board of Directors of the Medicines Company from July 2011 through December 31, 2015. Before joining The Medicines Company, Mr. Sblendorio was Executive Vice President and Chief Financial Officer of Eyetech Pharmaceuticals, Inc. from February 2002 until it was acquired by OSI Pharmaceuticals, Inc. in November 2005. Mr. Sblendorio also serves as a member of the Board of Directors of Intercept Pharmaceuticals, Inc. (Chair, Audit) and Mineralys Therapeutics, Inc.

Mr. Sblendorio received his B.B.A. from Pace University and his M.B.A. from Fairleigh Dickinson University

Mr. Sblendorio serves as chair of the Audit and Compliance Committee and as a member of the Compensation and Leadership Development Committee.

Back to Board of Directors